EyePoint, Inc. (EYPT) short interest & options flow
NASDAQEyePoint Pharmaceuticals adds a fresh Street voice this week, but the options market and a sticky short base tell a more cautious story ahead of its July 31 earnings event. The newest development is Cantor Fitzgerald's initiation on July 8, with analyst Steve Seedhouse assuming coverage at Overweight and a $47 price target. That adds a tenth buy-side voice to an already heavily…
- Market cap
- $31M
- Next earnings
- 12 Nov 2026
Key data as of 10 Nov 2026

EYPT news and analysis
RSSNo long-form analysis yet for EYPT. Pulse alerts and the live data picture are available on ORTEX.
Open EYPT on ORTEX →Want the live picture for EYPT?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EYPT — free to start on ORTEX.
Sign up for free →Open EYPT on ORTEX